Heyu Biological Technology Corporation reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was USD 0.016432 million compared to USD 0.029522 million a year ago. Net loss was USD 0.340876 million compared to USD 0.145306 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2501 USD | +12.35% | +12.35% | -28.30% |
04-01 | Hongchang International Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-01 | Hongchang International Co., Ltd Announces Board Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-28.30% | 130M | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- HCIL Stock
- News Hongchang International Co., Ltd
- Heyu Biological Technology Corporation Reports Earnings Results for the Half Year Ended June 30, 2023